have improved after acute myocardial infarction (MI) with earlier patient presentation and
widespread application of timely reperfusion therapy. However, patients with MI complicated …

Background; Interleukin (IL)-11 is a member of IL-6 cytokine family that is clinically used in
hematopoietic disorder. We have previously reported the preconditioning effects of IL-11 …

Activation of cardiac STAT3 by IL-6 cytokine family contributes to cardioprotection.
Previously, we demonstrated that IL-11, an IL-6 cytokine family, has the therapeutic potential …

We describe four cases of the patients with ST-elevation myocardial infarction (STEMI) that
were treated with interleukin-11 (IL-11), a cardioprotective cytokine. Recombinant human IL …

Abstract Funding Acknowledgements Type of funding sources: Foundation. Main funding
source (s): Novo Nordisk Fonden Background Cardiogenic shock (CS) is seen in up to 10 …

Introduction: Interleukin-6 (IL-6) is a proinflammatory cytokine, which is known to have a
close association with cardiovascular diseases. Although myocardial expression of …

Abstract Objective: Interleukin-10 (IL-10) exerts potent anti-inflammatory actions and
modulates matrix metalloproteinase expression. We hypothesized that endogenous IL-10 …

Abstract Background: Interleukin‐1 receptor antagonist (IL‐1 Ra) levels are elevated early in
patients with acute myocardial infarction (MI) and often precede release of markers of …

Abstract Interleukin-1 (IL-1) is the prototypical pro-inflammatory cytokine. IL-1 was implicated
as a cardiodepressant factor in septic shock, and subsequent pre-clinical and clinical …

Background and aims Myocardial infarction triggers an inflammatory response involved in
cardiac repair. We studied the association of the interleukin 6 (IL-6) cascade with infarct size …